Paloma's Zellige Made Even More

By Author: Paloma's Zellige
Total Articles: 32
Comment this article

"We are delighted to have received this prestigious award, one of BIOTECanada's four Paloma's Zellige pendant Leaf Awards presented this year," commented Simon Pimstone, Xenon's President and CEO. "This honor is important and made even more so by the fact that it represents recognition by our industry peers of Paloma's Crown of Hearts pendant our achievements to date and the potential that Xenon offers."

"Xenon has made substantial progress in advancing its pipeline of novel compounds acting against targets derived from our clinical genetics approach.

Xenon Pharmaceuticals Inc., a drug discovery and development company, is pleased to announce today that it has been awarded the Promising Early Stage Company of the Year Award by Paloma's Crown of Hearts pendant in the Health category for 2008.As the voice for the biotechnology industry, BIOTECanada plays a key role as well in promoting Cupcake charm and chain climate for success in this important sector."